Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010

Shiliang Liu,Jing Wen,Hong Yang,Qiaoqiao Li,Yuping Chen,Chengchu Zhu,Wentao Fang,Zhentao Yu,Weimin Mao,Jiaqing Xiang,Yongtao Han,Lei Zhao,Hui Liu,Yonghong Hu,Mengzhong Liu,Jianhua Fu,Mian Xi
DOI: https://doi.org/10.1016/j.ejca.2020.08.002
IF: 10.002
2020-10-01
European Journal of Cancer
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>The aim of this study was to compare recurrence patterns and prognostic factors for developing recurrences in patients with oesophageal squamous cell carcinoma (ESCC) who received neoadjuvant chemoradiotherapy (CRT) followed by surgery or surgery alone from a multicenter phase III trial NEOCRTEC5010.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Patients and methods</h3><p>Patients with locally advanced ESCC were randomly assigned in a 1:1 ratio to receive neoadjuvant CRT plus surgery (CRT + S group) or surgery alone (S group). CRT consisted of two cycles of vinorelbine and cisplatin with concurrent radiotherapy of 40.0 Gy in 20 fractions. Recurrence patterns, sites, frequency, and timing and potential prognostic factors were compared.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of the 451 patients enrolled from 2007 to 2014, 411 patients who underwent resection were analysed. After a median follow-up of 51.9 months, 62 patients (33.7%) in the CRT + S group versus 104 patients (45.8%) in the S group experienced recurrences (<em>P</em> = 0.013). The CRT + S group demonstrated a significantly better locoregional failure-free survival (<em>P</em> = 0.012) and a more favourable distant metastasis-free survival (<em>P</em> = 0.028) than the S group. Recurrences occurred earlier in the S group (<em>P</em> = 0.053), and late relapses were much more frequent in the CRT + S group (<em>P</em> = 0.029). On multivariate analysis, R1 resection and surgery alone were adverse factors for developing locoregional recurrences, whereas R1 resection was the only independent factor associated with distant metastases.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The neoadjuvant CRT regimen was associated with significantly reduced locoregional and distant recurrences compared with surgery alone. Recurrence patterns, sites and frequency were different between groups.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Trial registration ClinicalTrials.gov identifier</h3><p>NCT01216527.</p>
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to compare the recurrence patterns, sites, frequencies and potential prognostic factors in esophageal squamous cell carcinoma (ESCC) patients after surgery following neoadjuvant chemoradiotherapy (CRT) and after surgery alone. Based on the results of the multi - center phase III trial NEOCRTEC5010, the study aims to deeply understand the recurrence characteristics of ESCC under different treatment regimens, so as to guide the development of effective tertiary prevention and follow - up strategies. Specifically, the researchers hope to evaluate whether neoadjuvant chemoradiotherapy can effectively reduce the risks of local and distant recurrence and explore the possible prognostic factors affecting recurrence by comparing the recurrence situations of patients under two treatment methods (neoadjuvant chemoradiotherapy plus surgery vs surgery alone). This helps to provide more accurate treatment suggestions for clinicians and optimize the long - term management plans for patients.